ADHD Diagnosis in Australian Adults: What Criteria Are Needed, and What Does a Prescribing Doctor Require?

An adult ADHD diagnosis in Australia requires a comprehensive clinical assessment, not a single test or questionnaire. Under the DSM-5 criteria, a clinician must establish at least five symptoms of inattention and/or hyperactivity-impulsivity that have persisted for at least six months, evidence that some of those symptoms were present before the age of 12, functional impairment across at least two life domains (such as work, relationships, and daily functioning), and a thorough differential diagnosis confirming the symptoms are not better explained by another condition. For medication to be prescribed, a prescribing clinician (typically a psychiatrist or authorised GP) needs a diagnostic report that documents all of these elements with sufficient rigour to support confident prescribing decisions, including PBS eligibility information where relevant.

Image by Freepik

This article explains what a thorough adult ADHD assessment looks like in Australia, what assessment tools are used and why, what the prescribing doctor needs from the diagnostic report, and how the PBS subsidisation system works for adult ADHD medications. It is written from the perspective of a psychologist who conducts these assessments, and it is grounded in the Australian Evidence-Based Clinical Practice Guideline for ADHD (AADPA, 2022), NICE NG87, and the World Federation of ADHD International Consensus Statement (Faraone et al., 2021).

Why a Rigorous Diagnostic Process Matters

ADHD affects approximately one in 20 Australians, and it is increasingly being recognised in adults who were never identified in childhood. A 2026 University of Wollongong study found that the average cost of an adult ADHD assessment in Australia is nearly $1,400, with wait times averaging 10 weeks for psychologists and considerably longer for psychiatrists. Given this investment of time and money, the assessment needs to be done well the first time.

Recent Australian research has also highlighted a concerning finding. A study of 322 Australian psychologists involved in ADHD assessment found that fewer than half demonstrated adherence to the recommended assessment components outlined in the AADPA Guideline, and fewer than one in three correctly identified all the DSM-5 ADHD diagnostic criteria when tested (O’Toole, 2026). This is not an indictment of individual clinicians; it reflects gaps in training and standardisation. It does, however, underscore why consumers should understand what a comprehensive assessment involves.

The practical consequence of an incomplete assessment is significant. If the diagnostic report does not meet the evidentiary standard a prescribing psychiatrist expects, the psychiatrist may repeat the entire assessment from scratch, adding months and further expense. A thorough initial assessment saves everyone time.

The DSM-5 Diagnostic Criteria for Adult ADHD

Diagnostic criteria are drawn from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR, American Psychiatric Association, 2022). For adults aged 17 and over, the criteria require the following.

Symptom count. At least five symptoms from the inattention list and/or at least five from the hyperactivity-impulsivity list, persisting for at least six months. The threshold is reduced from six (used for children) to five for adults, reflecting the way symptom expression typically changes with age.

Age of onset. Several symptoms must have been present before the age of 12. This does not mean the person needed a childhood diagnosis. It means there must be evidence, from any source, that difficulties consistent with ADHD were present during childhood.

Pervasiveness. Symptoms must be present in two or more settings, such as at work and at home, or in relationships and during daily self-management.

Functional impairment. The symptoms must interfere with or reduce the quality of social, academic, or occupational functioning.

Differential diagnosis. The symptoms must not be better explained by another mental health condition, such as anxiety, depression, bipolar disorder, or a trauma response. Difficulty concentrating, for instance, appears in 17 different DSM-5 diagnostic criteria across various disorders (Suetani, Hull & Scott, 2026). ADHD cannot be diagnosed on the basis of inattention alone without careful differential reasoning.

The DSM-5 identifies three presentation types. Predominantly inattentive presentation involves at least five inattention symptoms without meeting the threshold for hyperactivity-impulsivity. Predominantly hyperactive-impulsive presentation is the reverse pattern. Combined presentation involves meeting the symptom threshold on both lists. The inattentive presentation is the most commonly missed in adults, and particularly in women, because it does not fit the stereotypical image of hyperactive ADHD.

What a Comprehensive ADHD Diagnosis and Assessment in Australian Adults Involves

The AADPA Guideline (2022), NICE NG87 (2018, updated 2024), and the World Federation of ADHD Consensus Statement (Faraone et al., 2021) all agree on the same fundamental point. ADHD can only be diagnosed through clinical interview and clinical judgement. It cannot be diagnosed by rating scales alone, neuropsychological testing, or brain imaging. Rating scales are adjunctive tools that support the clinical decision; they do not replace it.

A comprehensive assessment typically takes two to three sessions and involves several interconnected components.

Clinical Interview

The clinical interview is the foundation. It covers current presenting concerns and referral context, personal developmental history (birth, early childhood, schooling, academic trajectory), occupational history and current workplace functioning, relationship and social functioning, family psychiatric history, substance use history, medical history including sleep, and prior psychological or psychiatric treatment. The interview is where the clinician builds a picture of the person’s life that no questionnaire can capture.

Structured Diagnostic Interview

A structured or semi-structured diagnostic interview systematically assesses all 18 DSM-5 ADHD criteria across both adulthood and childhood. The DIVA-5 (Diagnostic Interview for ADHD in Adults), developed by Kooij and Francken, is widely used internationally and in Australian clinical practice. It provides concrete behavioural examples for each criterion and assesses impairment across five life domains, covering work and education, relationships and family, social contacts, leisure and hobbies, and self-confidence and self-image. Administration typically takes 60 to 90 minutes, and where possible a partner or family member should be present during the childhood history section to provide collateral verification.

The DIVA-5 generates a criterion-by-criterion record that documents exactly which symptoms are endorsed, with behavioural examples, in both current and childhood timeframes. This level of structured documentation is what gives a prescribing clinician confidence that the diagnosis has been made systematically rather than impressionistically.

Standardised Rating Scales

Rating scales administered through a psychometric platform (such as NovoPsych) provide quantified, norm-referenced data to complement the clinical interview. Standard instruments used in adult ADHD assessment include the following.

The ASRS (Adult ADHD Self-Report Scale) is a World Health Organization instrument that maps to all DSM-5 criteria. The six-item screener has strong screening accuracy (sensitivity 68.7%, specificity 99.5% in the original validation by Kessler et al., 2005), and the full 18-item version provides a comprehensive symptom profile. It is widely regarded as having the most extensive validation literature of any adult ADHD self-report measure.

The WURS-25 (Wender Utah Rating Scale) provides a standardised retrospective measure of childhood ADHD symptoms. It is particularly useful when school reports or parental informants are unavailable. When combined with the ASRS, research shows these instruments achieve an AUC of 0.964 in discriminating ADHD from non-ADHD presentations, providing strong diagnostic discrimination.

The ESQ-R (Executive Skills Questionnaire, Revised) provides an executive functioning profile across multiple domains. Research indicates that people with ADHD tend to show greater difficulty with behavioural regulation, while people with autism tend to show difficulties with planning and flexibility (Craig et al., 2016). This profile information supports the differential diagnostic formulation.

Comorbidity screening instruments are administered based on clinical presentation. These commonly include mood and anxiety measures (the DASS-21, PHQ-9 and GAD-7, or Zung SDS and GAD-7), trauma screening (the PCL-5 or ITQ), autism screening (the CATI), and bipolar screening (the MDQ). Bipolar differential diagnosis is particularly relevant because stimulant medications can destabilise bipolar disorder.

Collateral Information

Collateral evidence strengthens the diagnostic formulation and is required by the PBS for retrospectively diagnosed adults seeking subsidised medication. Sources include informant interviews (with a partner, parent, sibling, or close friend), school reports and academic records, prior psychological or psychiatric assessments, and relevant medical records. Where collateral informants are unavailable, this must be documented in the report and alternative evidence sources identified.

The Challenge of Proving Childhood Onset in Late-Diagnosed Adults

One of the most common barriers adults face is the requirement to demonstrate that symptoms were present before age 12, particularly when they were never identified in childhood. This is a well-documented limitation of adult ADHD assessment. A large birth cohort study found that self-reported recall of childhood symptoms at age 22 had an accuracy of only 55.4%, with a sensitivity of 32.8% (Matte et al., 2019).

Several factors compound the difficulty. ADHD itself impairs episodic memory encoding and retrieval, meaning the condition being assessed may degrade the person’s ability to recall the evidence needed. Adults who were never diagnosed as children may not have recognised their difficulties as symptoms at the time. Masking is common, particularly in women and high-achieving individuals who developed compensatory strategies that concealed underlying difficulties. Some clients have trauma histories that create dissociative memory gaps or cause trauma symptoms to overshadow ADHD symptoms in retrospective recall.

A thorough assessment addresses this through a tiered approach. The strongest evidence comes from informant interviews with parents. When parents are unavailable, siblings or longstanding family friends may contribute useful information. Contemporaneous documents, especially school reports with teacher comments on concentration, task completion, and behavioural consistency, are valuable because they are records made at the time rather than retrospective reconstructions. Structured rating scales like the WURS-25 use concrete behavioural examples that cue memory retrieval more effectively than open-ended interview questions. When direct evidence is limited, indirect developmental evidence, such as educational trajectory, early occupational instability, and the chronicity of the symptom pattern, can support a childhood onset inference.

Clinical note: The absence of childhood recall does not rule out ADHD. It is a common feature of the condition itself and of late-diagnosed presentations, particularly in women and high-achieving individuals who developed compensatory strategies that masked symptoms during childhood. A good assessment report addresses this directly rather than treating poor recall as evidence against the diagnosis.

What a Prescribing Doctor Needs From the Diagnostic Report

Psychologists diagnose ADHD. Psychologists do not prescribe medication. The diagnostic report therefore needs to give the prescribing clinician (a psychiatrist or authorised GP) everything they need to make a confident prescribing decision without repeating the entire assessment. The Australian Prescriber (Suetani, Hull & Scott, 2026) provides the current prescribing guidance for clinicians.

A report that meets this standard should include a DSM-5 diagnostic formulation with the identified presentation type (predominantly inattentive, predominantly hyperactive-impulsive, or combined), evidence of childhood onset before age 12 with the source of that evidence clearly identified, functional impairment documented across specific life domains with concrete examples, differential diagnostic reasoning that identifies conditions considered and ruled out (or identified as comorbid), a comorbidity profile with treatment priority recommendations, a response validity assessment addressing consistency across the measures administered and clinical observations about engagement and presentation credibility, a summary of collateral information and its consistency with self-report, PBS eligibility information (specifically whether the diagnosis is retrospective and what third-party evidence of childhood symptoms has been obtained), and treatment recommendations including whether pharmacological intervention is supported and any considerations relevant to prescribing (such as substance use history, cardiovascular risk flags, or comorbid conditions that may influence medication choice).

The Australian Prescriber specifies that physical assessment prior to pharmacotherapy should include heart rate, blood pressure, weight, and blood tests to exclude anaemia, thyroid dysfunction, and to establish baseline kidney and liver function. This is the prescribing clinician’s responsibility, but the psychology report should flag any medical history disclosed during interview that may be relevant to the prescribing decision.

PBS Medication Subsidisation for Adult ADHD

The Pharmaceutical Benefits Scheme has specific eligibility requirements for subsidised ADHD medications in adults. Understanding these requirements is important because they directly affect what the assessment report needs to document.

Lisdexamfetamine (Vyvanse) and Ritalin LA are PBS-subsidised for individuals diagnosed before 18 years of age or retrospectively diagnosed after 18, provided there is evidence of pre-existing childhood symptoms obtained from a parent, teacher, sibling, or other third party. Concerta (modified-release methylphenidate) is only PBS-subsidised for individuals diagnosed between 6 and 18 years of age. Atomoxetine is only PBS-subsidised for individuals diagnosed between 6 and 18 who have a contraindication to or are intolerant of stimulant treatment. Immediate-release methylphenidate (Ritalin) and dexamfetamine have no PBS age restrictions but are subject to jurisdictional Schedule 8 regulations.

The critical implication for the assessment is this: if the person was diagnosed retrospectively (as most adults are), the report must clearly document whether third-party evidence of childhood symptoms was obtained, and the nature and source of that evidence. Without this documentation, the prescribing clinician cannot make a PBS application for subsidised lisdexamfetamine or Ritalin LA. Some prescribing psychiatrists will accept a well-documented clinical formulation that triangulates multiple indirect sources when no third party is available. Others will require more traditional collateral evidence. The report should be transparent about the evidence base so the prescribing clinician can make an informed decision.

Why ADHD is Missed in Women and What Good Assessment Looks Like

ADHD has historically been conceptualised around male presentations, particularly the hyperactive-impulsive type that is most visible in childhood. Women and girls with ADHD are more likely to present with predominantly inattentive symptoms, to internalise their difficulties as anxiety, depression, or low self-esteem rather than externalising them as disruptive behaviour, and to develop sophisticated masking and compensatory strategies that conceal underlying executive functioning difficulties. As a result, women are significantly more likely to reach adulthood without a diagnosis.

A good assessment for ADHD in women should explicitly account for masking and compensation, explore the possibility that mood and anxiety symptoms are secondary to undiagnosed ADHD rather than primary conditions, use assessment tools that capture inattentive presentations (the DIVA-5 is particularly effective here because it provides concrete behavioural examples for each criterion that prompt recognition of inattentive patterns), and consider the interaction between ADHD and hormonal changes across the lifespan, including the common pattern of symptom exacerbation during perimenopause.

This is one of the reasons why a comprehensive clinical interview matters more than any screening questionnaire. A person who scores below the clinical threshold on a screening tool may still meet full DSM-5 criteria when their symptoms are explored in depth through a structured diagnostic interview with a clinician who understands female ADHD presentations.

Who Can Diagnose ADHD in Australia?

In Australia, ADHD can be diagnosed by psychologists, psychiatrists, and paediatricians. In Queensland, and as of 2026 through pilot programmes in New South Wales and Victoria, specially trained GPs can also diagnose and initiate treatment. Psychologists cannot prescribe medication, which means that after a psychologist provides the diagnosis, the person will need to see a prescribing clinician (typically a psychiatrist) for medication management if that is the chosen treatment pathway.

One of the practical challenges in the current system is that psychologists vastly outnumber psychiatrists and paediatricians in the Australian workforce, yet some psychiatrists will re-assess patients who present with a psychologist’s diagnosis before prescribing. This is understandable given that the psychiatrist carries the prescribing responsibility for a Schedule 8 medication. The best way to reduce the likelihood of a repeat assessment is to provide a diagnostic report that meets the evidentiary standard the prescribing clinician needs, which is the purpose of the protocol described in this article.

Frequently Asked Questions

Can a psychologist diagnose ADHD in Victoria?

Yes. General psychologists in Victoria can diagnose ADHD with appropriate training. No specific endorsement is required for ADHD diagnosis, but the psychologist should demonstrate competence in standardised diagnostic assessment tools and familiarity with the AADPA Guideline (2022).

How long does an adult ADHD assessment take?

A thorough assessment typically requires two to three sessions, consistent with the AADPA Guideline recommendation that a comprehensive assessment may require multiple sessions. The first session involves a detailed clinical interview. The second session involves administration of a structured diagnostic interview (such as the DIVA-5), review of rating scale results, and discussion of the clinical formulation. A third session may be needed for complex presentations involving differential diagnosis with autism, personality difficulties, or complex trauma.

What is the DIVA-5?

The DIVA-5 (Diagnostic Interview for ADHD in Adults, 5th Edition) is a semi-structured diagnostic interview developed by Kooij and Francken. It systematically assesses all 18 DSM-5 ADHD criteria in both adulthood and childhood, using concrete behavioural examples for each criterion. Validation studies report diagnostic accuracy of 92% (Hong et al., 2020). It is widely used internationally and is referenced in the AADPA Guideline.

Can ADHD be diagnosed with a questionnaire or online screening tool?

No. Screening tools such as the ASRS indicate the likelihood of ADHD; they do not confirm a diagnosis. The World Federation of ADHD Consensus Statement (Faraone et al., 2021, endorsed by 80 authors from 27 countries) confirms that ADHD can only be diagnosed through clinical interview and clinical judgement. Rating scales, neuropsychological tests, and brain imaging cannot diagnose or rule out ADHD on their own.

What if I do not have school reports or a parent who can provide childhood history?

This is common among late-diagnosed adults. A thorough assessment uses a tiered strategy, working through informant interviews, contemporaneous documents, structured retrospective rating scales (the WURS-25 is designed for exactly this purpose), and indirect developmental evidence. The assessment report should document what steps were taken to obtain collateral information, what was obtained, and what remained unavailable. The absence of childhood records does not prevent a diagnosis if the clinical evidence is sufficient.

How much does an adult ADHD assessment cost in Australia?

Costs vary by provider for ADHD diagnosis in Australian adults. University of Wollongong research published in 2026 found that the average initial assessment for an adult cost more than $530 without rebates, with total assessment costs averaging nearly $1,400 and reaching almost $4,000 in some cases. Medicare rebates may apply if you have a GP Mental Health Treatment Plan referral. Fees should be discussed with your provider before the assessment begins.

Have a look at what Behavioural Edge Psychology charges.

Do I have to take medication after an ADHD diagnosis?

Medication is one evidence-based treatment option. It is not mandatory. Many adults benefit from psychological strategies including CBT adapted for ADHD, coaching, environmental modifications, and workplace accommodations, either alongside medication or as an alternative. The AADPA Guideline recommends a multimodal treatment approach that considers the person’s preferences and circumstances. A good diagnostic assessment provides recommendations across multiple treatment domains, not just medication.

References

• Australasian ADHD Professionals Association (AADPA). (2022). Australian Evidence-Based Clinical Practice Guideline for Attention Deficit Hyperactivity Disorder. Melbourne, VIC, Australia: AADPA.

• AADPA. (2024). ADHD Prescribing Guide for Australian Healthcare Professionals. Melbourne, VIC, Australia: AADPA.

• Craig, F., Margari, F., Legrottaglie, A.R., Palumbi, R., de Giambattista, C., & Margari, L. (2016). A review of executive function deficits in autism spectrum disorder and attention-deficit/hyperactivity disorder. Neuropsychiatric Disease and Treatment, 12, 1191–1202.

• Faraone, S.V., Banaschewski, T., Coghill, D., et al. (2021). The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, 789–818.

• Hong, M., Lee, S.Y., Bahn, G.H., et al. (2020). Validity of the Korean Version of DIVA-5. Psychiatry Investigation, 17(10), 1028–1038.

• Kessler, R.C., Adler, L., Ames, M., et al. (2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychological Medicine, 35(2), 245–256.

• Matte, B., Rohde, L.A., & Grevet, E.H. (2019). Revisiting ADHD age-of-onset in adults: to what extent should we rely on the recall of childhood symptoms? Psychological Medicine, 49(9), 1502–1507.

• National Institute for Health and Care Excellence (NICE). (2018, updated 2024). Attention deficit hyperactivity disorder: diagnosis and management (NG87). London: NICE.

• O’Toole, C. (2026). Psychologists’ assessment practices for ADHD in Australia. PhD research, University of Wollongong. Published findings reported in The Conversation and UOW media, March–April 2026.

• Suetani, S., Hull, J., & Scott, J.G. (2026). Pharmacological management of attention deficit hyperactivity disorder in adults. Australian Prescriber, 49, 10–15.

• Zamani, L., Shahrivar, Z., Alaghband-Rad, J., et al. (2021). Reliability, Criterion and Concurrent Validity of the Farsi Translation of DIVA-5. Journal of Attention Disorders, 25(5), 654–663.

About the author

Dr Sarah Fischer

Dr Fischer is the Principal Psychologist at Behavioural Edge Psychology in Melbourne, Victoria. She holds a PhD and Master of Psychology (AHPRA registration PSY0001719709). Her practice specialises in adult ADHD and autism assessment, workplace psychology, and medicolegal reporting. She uses the DIVA-5 structured diagnostic interview and NovoPsych psychometric platform in her ADHD assessment protocol, and her diagnostic reports are designed to meet the evidentiary requirements of prescribing psychiatrists and the PBS. Behavioural Edge Psychology operates from consulting rooms in Caulfield South and St Kilda.

To book an adult ADHD assessment or discuss whether an assessment is appropriate for your situation, contact Behavioural Edge Psychology on 03 8771 4315 or visit www.behaviouraledgepsychology.com.